Replies to post #298233 on Anavex Life Sciences Corp (AVXL)

[xodcode]

Totally agree with your outlook that we are at one inflection point of several going forward.

AVXL is in for a great deal of MC appreciation over the next 18 months assuming continued blarcamesine positive trending results at which time we will be looking back on today's price machinations as wholly unimportant.

Speaking of today's volatility, I can't help but think options expiration tomorrow is a large contributing factor.

very much looking forward to tonight's conference call.

[abew4me]

Great find, Jimmy.

I looked at the multi-year chart for ARWR. Wow!!!...It looks like the September 16th announcement is what started the ball rolling. Interesting that it was an interim 24-week biopsy result on just four subjects that caused a huge spike in volume of 24MM shares x $50/share.

Hmm...I believe we have the option to report an interim for the AD trial as well. Nice!

**********************************************************************************************


*Arrowhead Pharmaceuticals shares are trading higher after the company announced positive interim 24-week liver biopsy results in four subjects from AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT, the company's second-generation investigational RNA interference therapeutic.(Benzinga)